California Makes a $25 Million Kidney Transplant Wager: Its 44th Stem Cell Clinical Trial
The California stem cell agency this week more than doubled down on its bet on a potentially breakthrough treatment for kidney transplants, raising to $25.4 million its support for a project that is entering its final stages.
The hope is that the treatment will not only improve the success rate of kidney transplants but also lead to use in liver, heart a…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.